Envoy Medical, Inc. (COCH) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Envoy Medical, Inc. on May 19, 2025, covering events occurring on May 16, 2025. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in White Bear Lake, MN. Its Class A Common Stock and Redeemable Warrants trade on The Nasdaq Stock Market LLC under the symbols COCH and COCHW, respectively.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change in principal officers and does not contain financial statements or performance data.
Material Changes
- Departure of CFO: Effective May 16, 2025, David R. Wells ceased serving as Chief Financial Officer.
- Reason for Departure: The separation was without cause.
- Compensation: Mr. Wells is entitled to separation compensation pursuant to his Employment Agreement dated August 15, 2023.
- Interim Leadership: Chief Executive Officer Brent T. Lucas will serve as the principal financial officer on an interim basis until a successor is appointed.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on operations, specific risks, or contingencies beyond the executive transition. No unusual items were disclosed in this report.
Key Facts for Investor Verification
- Verify the specific terms and total value of the separation compensation owed to the departing CFO under the August 2023 Employment Agreement.
- Monitor the timeline for the appointment of a permanent successor to the Chief Financial Officer role.
- Confirm the impact of the interim CFO arrangement on the Company's upcoming financial reporting cycle.